Sign In
Buy APGE
Apogee Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -63.48. In total, the insiders bought 1.24M and sold 2.04M APGE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-63.48 |
| ● Buy | 1.24M shares |
| ● Sell | 2.04M shares |
|
23% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 14, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
5 386 Value: $447.9K |
||
|
Jan 14, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
1 854 Value: $152.8K |
||
|
Jan 14, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
2 374 Value: $192.3K |
||
|
Jan 14, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
8 476 Value: $676.6K |
||
|
Jan 14, 2026 Sell |
Henderson Michael Thomas Chief Executive Officer |
1 440 Value: $113.2K |
||
|
Jan 07, 2026 Buy |
Dambkowski Carl Chief Medical Officer |
14 025 Value: $320.6K |
||
|
Jan 07, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
100 Value: $8K |
||
|
Jan 07, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
826 Value: $65.3K |
||
|
Jan 07, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
14 820 Value: $1.15M |
||
|
Jan 07, 2026 Sell |
Dambkowski Carl Chief Medical Officer |
2 954 Value: $227.8K |
||
|
Jan 07, 2026 Buy |
Dambkowski Carl Chief Medical Officer |
14 025 Value: $320.6K |
||
|
Jan 06, 2026 Sell |
Henderson Jane Chief Financial Officer |
2 000 Value: $160.0K |
||
|
Jan 02, 2026 Buy |
Henderson Jane Chief Financial Officer |
83 690 Value: $6.34M |
||
|
Jan 02, 2026 Sell |
Henderson Jane Chief Financial Officer |
4 080 Value: $306.8K |
||
|
Jan 02, 2026 Sell |
Henderson Jane Chief Financial Officer |
1 920 Value: $142.3K |
||
|
Jan 02, 2026 Buy |
Henderson Michael Thomas Chief Executive Officer |
253 016 Value: $19.2M |
||
|
Jan 02, 2026 Buy |
Dambkowski Carl Chief Medical Officer |
83 690 Value: $6.34M |
||
|
Dec 19, 2025 Sell |
Henderson Jane Chief Financial Officer |
1 500 Value: $120.0K |
||
|
Dec 10, 2025 Sell |
Henderson Michael Thomas Chief Executive Officer |
560 Value: $42.9K |
||
|
Dec 10, 2025 Sell |
Henderson Michael Thomas Chief Executive Officer |
10 005 Value: $758.3K |
||
|
Dec 10, 2025 Sell |
Henderson Michael Thomas Chief Executive Officer |
9 435 Value: $706.5K |
||
|
Dec 04, 2025 Sell |
Henderson Michael Thomas Chief Executive Officer |
40 000 Value: $3.00M |
||
|
Dec 04, 2025 Sell |
Henderson Jane Chief Financial Officer |
1 500 Value: $112.5K |
||
|
Dec 04, 2025 Sell |
Dambkowski Carl Chief Medical Officer |
10 900 Value: $817.5K |
||
|
Nov 25, 2025 Sell |
Henderson Jane Chief Financial Officer |
1 500 Value: $105.0K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
